Studies on serum Interleukin-35 (IL-35), and mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1) propose low IL-35, and high MALT1, respectively, to be potential biomarkers for renal involvement in SLE patients (20, 21). The gene discussed is MALT1; the disease is systemic lupus erythematosus.